Jelle Wesseling

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

Chong Sun, Liqin Wang, Sidong Huang et al. · Nature · 2014 · 910 citations · Full text

Medicine, Molecular Biology, Oncology +11

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Jelle Wesseling, S W van der Valk, Hans L. Vos et al. · The Journal of Cell Biology · 1995 · 494 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Roger L. Milne, Karoline Kuchenbaecker, Kyriaki Michailidou et al. · Nature Genetics · 2017 · 471 citations · Full text

Medicine, Genetics, Oncology +12

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

Mette S. van Ramshorst, Anna van der Voort, Erik van Werkhoven et al. · The Lancet Oncology · 2018 · 445 citations · Full text

Medicine, Oncology, Breast Oncology +15

Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients

Mila Donker, Marieke E. Straver, Jelle Wesseling et al. · Annals of Surgery · 2014 · 423 citations · Full text

Medicine, Nuclear Medicine, Oncology +17